{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T11:23:26Z","timestamp":1777807406131,"version":"3.51.4"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K06945"],"award-info":[{"award-number":["JP23K06945"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K07351"],"award-info":[{"award-number":["JP22K07351"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24H00067"],"award-info":[{"award-number":["JP24H00067"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K02371"],"award-info":[{"award-number":["JP24K02371"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21K07464"],"award-info":[{"award-number":["JP21K07464"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["24wm0625504s01001"],"award-info":[{"award-number":["24wm0625504s01001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23ek0109626h0001"],"award-info":[{"award-number":["23ek0109626h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23FC1009"],"award-info":[{"award-number":["23FC1009"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020964","name":"Japan Science and Technology Agency Fusion Oriented REsearch for disruptive Science and Technology","doi-asserted-by":"publisher","award":["JPMJFR200U"],"award-info":[{"award-number":["JPMJFR200U"]}],"id":[{"id":"10.13039\/501100020964","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jneuroim.2025.578615","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T08:10:44Z","timestamp":1744618244000},"page":"578615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Associations between serum levels of alpha-calcitonin gene-related peptide and clinical features of neuromyelitis optica spectrum disorders"],"prefix":"10.1016","volume":"404","author":[{"given":"Yuka","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru Yoshida","family":"Kashu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuhisa","family":"Masaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eizo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuu-ichi","family":"Kira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Yamaura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jneuroim.2025.578615_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030711","article-title":"CGRP induces differential regulation of cytokines from satellite glial cells in trigeminal ganglia and orofacial nociception","volume":"20","author":"Afroz","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578615_bb0010","article-title":"Pain in AQP4-IgG-positive and MOG-IgG-positive neuromyelitis optica spectrum disorders","volume":"4","author":"Asseyer","year":"2018","journal-title":"Multipl. Scler. J. - Exper. Transl. Clin."},{"key":"10.1016\/j.jneuroim.2025.578615_bb0015","doi-asserted-by":"crossref","first-page":"778","DOI":"10.3389\/fneur.2020.00778","article-title":"Pain in NMOSD and MOGAD: a systematic literature review of pathophysiology, symptoms, and current treatment strategies","volume":"11","author":"Asseyer","year":"2020","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578615_bb0020","article-title":"Pain, depression, and quality of life in Neuromyelitis Optica Spectrum disorder: a cross-sectional study of 166 AQP4 antibody-seropositive patients","volume":"8","author":"Ayzenberg","year":"2021","journal-title":"Neurol.(R) Neuroimmunol. Neuroinflamm."},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578615_bb0025","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1474-4422(15)00249-5","article-title":"Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study","volume":"14","author":"Bigal","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2025.578615_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2022.103244","article-title":"Advanced spinal cord MRI in multiple sclerosis: current techniques and future directions","volume":"36","author":"Combes","year":"2022","journal-title":"NeuroImage. Clin."},{"issue":"1\u20132","key":"10.1016\/j.jneuroim.2025.578615_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jneuroim.2011.05.013","article-title":"Trigeminal satellite cells express functional calcitonin gene-related peptide receptors, whose activation enhances interleukin-1\u03b2 pro-inflammatory effects","volume":"237","author":"De Corato","year":"2011","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578615_bb0040","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S1474-4422(14)70209-1","article-title":"Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial","volume":"13","author":"Dodick","year":"2014","journal-title":"Lancet Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578615_bb0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/head.13211","article-title":"CGRP and PTX3 as predictors of efficacy of onabotulinumtoxin type a in chronic migraine: an observational study","volume":"58","author":"Dom\u00ednguez","year":"2018","journal-title":"Headache"},{"issue":"8","key":"10.1016\/j.jneuroim.2025.578615_bb0050","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1097\/j.pain.0000000000000492","article-title":"Neuropathic pain: an updated grading system for research and clinical practice","volume":"157","author":"Finnerup","year":"2016","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.jneuroim.2025.578615_bb0055","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000841","article-title":"Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology","volume":"7","author":"Fujihara","year":"2020","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578615_bb0060","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-024-01769-4","article-title":"Untangling the mess of CGRP levels as a migraine biomarker: an in-depth literature review and analysis of our experimental experience","volume":"25","author":"G\u00e1rate","year":"2024","journal-title":"J. Headache Pain"},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578615_bb0065","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ana.26658","article-title":"Serum alpha and Beta-CGRP levels in chronic migraine patients before and after monoclonal antibodies against CGRP or its receptor","volume":"94","author":"G\u00e1rate","year":"2023","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578615_bb0070","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/head.13064","article-title":"CGRP and its receptors","volume":"57","author":"Hay","year":"2017","journal-title":"Headache"},{"issue":"10","key":"10.1016\/j.jneuroim.2025.578615_bb0075","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","article-title":"CGRP and its receptors provide new insights into migraine pathophysiology","volume":"6","author":"Ho","year":"2010","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578615_bb0080","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12883-021-02171-2","article-title":"Correlations among disability, anti-AQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD","volume":"21","author":"Hsu","year":"2021","journal-title":"BMC Neurol."},{"issue":"3","key":"10.1016\/j.jneuroim.2025.578615_bb0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1177\/1352458516687043","article-title":"Short segment myelitis as a first manifestation of neuromyelitis optica spectrum disorders","volume":"23","author":"Huh","year":"2017","journal-title":"Multip. Scler. (Houndmills, Basingstoke, Engl.)"},{"key":"10.1016\/j.jneuroim.2025.578615_bb0090","author":"IASP Terminology"},{"issue":"7","key":"10.1016\/j.jneuroim.2025.578615_bb0095","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/WNL.0b013e318229e694","article-title":"Pain in neuromyelitis optica and its effect on quality of life: a cross-sectional study","volume":"77","author":"Kanamori","year":"2011","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578615_bb0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/mus.27153","article-title":"Anti-calcitonin gene-related peptide monoclonal antibodies for neuropathic pain in patients with migraine headache","volume":"63","author":"Kang","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2025.578615_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2018.01249","article-title":"The role of calcitonin gene related peptide (CGRP) in neurogenic vasodilation and its cardioprotective effects","volume":"9","author":"Kee","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.jneuroim.2025.578615_bb0110","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"issue":"14","key":"10.1016\/j.jneuroim.2025.578615_bb0115","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/WNL.0000000000001441","article-title":"Differential patterns of spinal cord and brain atrophy in NMO and MS","volume":"84","author":"Liu","year":"2015","journal-title":"Neurology"},{"issue":"1\u20133","key":"10.1016\/j.jneuroim.2025.578615_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.regpep.2011.05.014","article-title":"Calcitonin gene-related peptide prevents blood-brain barrier injury and brain edema induced by focal cerebral ischemia reperfusion","volume":"171","author":"Liu","year":"2011","journal-title":"Regul. Pept."},{"issue":"8008","key":"10.1016\/j.jneuroim.2025.578615_bb0125","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41586-024-07237-y","article-title":"CGRP sensory neurons promote tissue healing via neutrophils and macrophages","volume":"628","author":"Lu","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2025.578615_bb0130","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/brain\/awm047","article-title":"Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis","volume":"130","author":"Misu","year":"2007","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578615_bb0135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pain.2007.08.024","article-title":"Pain associated with multiple sclerosis: systematic review and proposed classification","volume":"137","author":"O\u2019Connor","year":"2008","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jneuroim.2025.578615_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/s10194-024-01753-y","article-title":"CGRP-targeted medication in chronic migraine - systematic review","volume":"25","author":"Oliveira","year":"2024","journal-title":"J. Headache Pain"},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578615_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040133","article-title":"Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica","volume":"4","author":"Paul","year":"2007","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.jneuroim.2025.578615_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071500","article-title":"The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica","volume":"8","author":"Pellkofer","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578615_bb0155","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1001\/archneurol.2012.768","article-title":"Association of neuromyelitis optica with severe and intractable pain","volume":"69","author":"Qian","year":"2012","journal-title":"Arch. Neurol."},{"issue":"5922","key":"10.1016\/j.jneuroim.2025.578615_bb0160","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/304129a0","article-title":"Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing","volume":"304","author":"Rosenfeld","year":"1983","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578615_bb0165","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1152\/physrev.00034.2013","article-title":"Calcitonin gene-related peptide: physiology and pathophysiology","volume":"94","author":"Russell","year":"2014","journal-title":"Physiol. Rev."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578615_bb0170","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1152\/physrev.00059.2021","article-title":"CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond","volume":"103","author":"Russo","year":"2023","journal-title":"Physiol. Rev."},{"issue":"6","key":"10.1016\/j.jneuroim.2025.578615_bb0175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/bpa.12087","article-title":"Clinical spectrum and treatment of neuromyelitis optica spectrum disorders: evolution and current status","volume":"23","author":"Sato","year":"2013","journal-title":"Brain Pathol."},{"issue":"14","key":"10.1016\/j.jneuroim.2025.578615_bb0180","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/WNL.0b013e3182a6cc33","article-title":"Is CGRP a marker for chronic migraine? [review of is CGRP a marker for chronic migraine?]","volume":"81","author":"Silberstein","year":"2013","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578615_bb0185","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00415-012-6579-2","article-title":"A mechanism-based classification of pain in multiple sclerosis","volume":"260","author":"Truini","year":"2013","journal-title":"J. Neurol."},{"issue":"9","key":"10.1016\/j.jneuroim.2025.578615_bb0190","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","article-title":"The spectrum of neuromyelitis optica","volume":"6","author":"Wingerchuk","year":"2007","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.jneuroim.2025.578615_bb0195","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578615_bb0200","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/j.pain.0000000000000831","article-title":"The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine","volume":"158","author":"Yengar","year":"2017","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.jneuroim.2025.578615_bb0205","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neurol.2022.10.005","article-title":"High plasma calcitonin gene-related peptide and serum pituitary adenylate cyclase-activating polypeptide levels in patients with neuropathic pain","volume":"179","author":"Yevgi","year":"2023","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2025.578615_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104213","article-title":"Factors correlated with neuropathic pain in patients with neuromyelitis optica spectrum disorder","volume":"68","author":"Zhang","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"12","key":"10.1016\/j.jneuroim.2025.578615_bb0215","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1177\/1352458514522103","article-title":"Neuropathic pain in neuromyelitis optica affects activities of daily living and quality of life","volume":"20","author":"Zhao","year":"2014","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2025.578615_bb0220","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-024-05934-y","article-title":"Topical application of calcitonin gene-related peptide as a regenerative, antifibrotic, and immunomodulatory therapy for corneal injury","volume":"7","author":"Zidan","year":"2024","journal-title":"Commun. Biol."},{"issue":"11","key":"10.1016\/j.jneuroim.2025.578615_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047213","article-title":"Monoaminergic modulation of spinal viscero-sympathetic function in the neonatal mouse thoracic spinal cord","volume":"7","author":"Zimmerman","year":"2012","journal-title":"PLoS One"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572825000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:49:50Z","timestamp":1777495790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572825000967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":45,"alternative-id":["S0165572825000967"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578615","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between serum levels of alpha-calcitonin gene-related peptide and clinical features of neuromyelitis optica spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2025.578615","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"578615"}}